Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BIT/1ORNBV stock hub

BIT/1ORNBV has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BIT/1ORNBVis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

9.7B

Borsa Italiana

Market data

Live price

Current market quote for this ticker.

Current price

BIT/1ORNBV

In the news

Latest news · BIT/1ORNBV

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.9

P25 n/aP50 n/aP75 n/a

Trailing P/E18.2

P25 n/aP50 n/aP75 n/a

ROE48.4

P25 n/aP50 n/aP75 n/a

ROIC39.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BIT/1ORNBV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

212

Groups with data

Currency

EUR

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Finland
Country code	IT
Employees	4,132
Employees Change	163%
Employees Change Percent	4.22
Enterprise value	EUR 9.8B
Exchange	Borsa Italiana
Financial currency	EUR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 9.7B
Price	EUR 71.15
Price currency	EUR
Rev Per Employee	472,555.66x
Sic	2834
Symbol	bit/1ORNBV
Website	https://www.orionpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.48%
EV Earnings	18.48x
EV/EBIT	14.63x
EV/EBITDA	13.46x
EV/FCF	48.93x
EV/Sales	5.01x
FCF yield	2.07%
Forward P/E	15.87x
P/B ratio	8.6x
P/E ratio	18.24x
P/S ratio	4.94x
PE Ratio10 Y	22.42x
PE Ratio3 Y	22.5x
PE Ratio5 Y	23.19x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	34.25%
EBITDA Margin	36.91%
FCF margin	10.24%
Gross margin	64.8%
Gross Profit	EUR 1.3B
Gross Profit Growth	29.42%
Gross Profit Growth Q	25.87%
Gross Profit Growth3 Y	14.51%
Gross Profit Growth5 Y	15.17%
Net Income	EUR 529.4M
Net Income Growth	52.39%
Net Income Growth Q	47.47%
Net Income Growth3 Y	16.36%
Net Income Growth5 Y	20.07%
Pretax Margin	34.02%
Profit Margin	27.11%
Profit Per Employee	EUR 128,122
ROA	22.11
Roa5y	16.95
ROCE	52.22
ROE	48.36
Roe5y	34.21
ROIC	39.73
Roic5y	35.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	35.02%
Cagr3y	22.81%
Cagr5y	18.63%
Div CAGR3	30.5%
Div CAGR5	3.71%
EPS Growth	52.06
EPS Growth Q	46.74
EPS Growth3 Y	16.29
EPS Growth5 Y	20.17
FCF Growth	-1.04%
FCF Growth Q	-67.5%
FCF Growth3 Y	-16.6%
FCF Growth5 Y	-4.43%
OCF Growth	5.98%
OCF Growth Q	-52.2%
OCF Growth10 Y	1.23%
OCF Growth3 Y	-11.96%
OCF Growth5 Y	-0.51%
Revenue Growth	22.92x
Revenue Growth Q	17.8x
Revenue Growth3 Y	13.15x
Revenue Growth5 Y	12.85x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.03
Assets	EUR 2.1B
Cash	EUR 199.3M
Current Assets	EUR 1.4B
Current Liabilities	EUR 798.6M
Debt	EUR 330.3M
Debt EBITDA	EUR 0.45
Debt Equity	EUR 0.29
Debt FCF	EUR 1.65
Equity	EUR 1.1B
Interest Coverage	77.76
Liabilities	EUR 956.7M
Long Term Assets	EUR 667.9M
Long Term Liabilities	EUR 158.1M
Net Cash	EUR -131M
Net Cash By Market Cap	EUR -1.36
Net Debt EBITDA	EUR 0.18
Net Debt Equity	EUR 0.12
Net Debt FCF	EUR 0.66
Tangible Book Value	EUR 933.1M
Tangible Book Value Per Share	EUR 6.62

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.77
Inventory Turnover	1.45
Net Working Capital	EUR 633M
Quick ratio	1.13
Working Capital	EUR 612.6M
Working Capital Turnover	EUR 2.77

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.1%
Dividend Growth	9.76%
Dividend Growth Years	3%
Dividend per share	EUR 1.8
Dividend Years	8
Dividend Yield	2.45%
Ex Div Date	2026-10-19
Last Dividend	EUR 0.9
Payout Frequency	Semi-Annual
Payout Ratio	43.65%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	34.99%
200-day SMA	67.39
3Y total return	85.23%
50-day SMA	70.74
50-day SMA vs 200-day SMA	50over200
5Y total return	134.94%
All Time High	78.15
All Time High Change	-5.89%
All Time High Date	2026-04-17
All Time Low	31.27
All Time Low Change	135.21%
All Time Low Date	2020-03-16
ATR	1.42
Ch YTD	15.74
High52	78.15
High52 Date	2026-04-17
High52ch	-8.96%
Low52	52.55
Low52 Date	2025-05-12
Low52ch	35.4%
Ma50ch	3.98%
Price vs 200-day SMA	9.14%
RSI	48.71
RSI Monthly	67.14
RSI Weekly	54.3
Sharpe ratio	0.83x
Sortino ratio	1.41
Total Return	2.35%
Tr YTD	17.31
Tr1m	0.82%
Tr1w	4.47%
Tr3m	0.54%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 668.7M
Operating Income Growth	40.28
Operating Income Growth Q	47.43
Operating Income Growth3 Y	16.51
Operating Income Growth5 Y	19.86
Operating margin	34.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	123,112,532%
Net Borrowing	-3,000,000
Shares Insiders	8.75%
Shares Institutions	38.68%
Shares Qo Q	-0.05%
Shares Yo Y	0.1%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 200M
Average Volume	2.35x
Bv Per Share	7.97
CAPEX	EUR -76.4M
Ch1m	0.82
Ch1w	4.47
Ch1y	31.57
Ch3m	-0.81
Ch3y	70.73
Ch5y	101.2
Ch6m	30.18
Change	-1.25%
Close	72.05
Depreciation Amortization	52,100,000
Earnings Date	2026-04-23
EBIT	EUR 668.7M
EBITDA	EUR 720.8M
EPS	EUR 3.76
F Score	6
FCF	EUR 200M
FCF EV Yield	2.04x
Financing CF	-234,000,000
Fiscal Year End	December
Founded	1,917
Goodwill	87,200,000
Graham Number	26.94566
Graham Upside	-62.13
Income Tax	EUR 134.9M
Investing CF	-102,600,000
Is Primary Listing	0
Last Earnings Date	2026-04-23
Last Report Date	2026-03-31
Lynch Fair Value	EUR 78.32
Lynch Upside	10.07
Ma150	67.29
Ma150ch	9.3%
Ma20	72.73
Ma20ch	1.13%
Net CF	-60,100,000
Next Earnings Date	2026-07-17
P FCF Ratio	48.27
P OCF Ratio	34.93
Payment Date	2026-10-21
Ppne	458,200,000
Price Date	2026-05-08
Price EBITDA	EUR 13.39
Ptbv Ratio	10.35
Relative Volume	947.37x
Revenue	1,952,600,000x
Tax By Revenue	6.91x
Tax Rate	20.31%
Tr6m	31.94%
Z Score	8.69

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BIT/1ORNBV dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.4%

$1.80 annual per share

Payout ratio

+43.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+3.7%

3 consecutive years of growth

Total shareholder yield

+2.3%

Next ex-dividend date: 2026-10-19

Performance

BIT/1ORNBV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BIT/1ORNBV?

Insider, institutional, and short-interest positioning.

Institutional ownership

+38.7%

Share of float held by funds and institutions

Insider ownership

+8.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

BIT/1ORNBV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.7

Neutral momentum band

Price vs 200-day MA

+9.1%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.83

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BIT/1ORNBV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bit/1ORNBV stock rating?

bit/1ORNBV is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bit/1ORNBV analysis?

The full report lives at /stocks/bit/1ORNBV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bit/1ORNBV?

The latest report frames bit/1ORNBV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bit/1ORNBV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.